Autophagy: Cellular Renewal and Recycling

Autophagy represents one of the most fundamental and evolutionary conserved mechanisms by which eukaryotic cells maintain homeostasis, preserve proteostasis, and endure conditions of nutrient scarcity. Far from being a mere waste disposal system, this dynamic catabolic process acts as a sophisticated quality control and recycling network that orchestrates cellular survival, metabolic adaptation, and programmed turnover of dysfunctional organelles. Understanding the molecular machinery and physiological relevance of autophagy has revolutionized contemporary cell biology, offering transformative insights into neurodegeneration, oncology, infectious disease, and healthy human longevity.

Autophagy

1. Concise Definition

Autophagy is a highly conserved, lysosome-dependent catabolic pathway in eukaryotic cells responsible for the degradation and recycling of cytoplasmic constituents, including damaged organelles, misfolded protein aggregates, and intracellular pathogens. Through the sequestration of targeted cargo into double-membrane vesicles called autophagosomes and their subsequent fusion with lysosomes, the cell digests internal components to regenerate essential biosynthetic intermediates and metabolic energy.

In broader physiological contexts, autophagy operates as an indispensable cellular quality control mechanism. Basal levels of autophagy maintain everyday cellular integrity by purging toxic macromolecules, while stress-induced upregulation serves as an adaptive survival response during starvation, hypoxia, oxidative stress, and mechanical damage. Beyond cell survival, orchestrated autophagy plays instrumental roles in development, cellular differentiation, innate and adaptive immunity, and the modulation of programmed cell death pathways.

2. Etymology & Linguistic Origin

The term autophagy is derived directly from classical Greek roots: the prefix auto- (Greek: αὐτο-, meaning “self”) and the nominalized root derived from the verb phagein (Greek: φαγεῖν, meaning “to eat” or “to devour”). Compounded into New Latin as autophagia, the literal translation of the term is “self-eating” or “self-consumption.”

The concept of self-digestion historically appeared in 19th-century physiological and pathological treatises describing tissue wasting and self-nourishment during severe starvation. However, the precise modern cytological application of the term was coined in 1963 by the Belgian biochemist Christian de Duve. While elucidating the structure and digestive functions of lysosomes through biochemical fractionation, de Duve recognized that cells could deliberately engulf portions of their own cytoplasm inside membrane-bound vesicles, introducing “autophagy” to distinguish this intracellular self-digestion from heterophagy, the lysosomal degradation of extracellular material.

3. Pronunciation & Grammatical Form

Pronunciation: The standard pronunciation in International Phonetic Alphabet (IPA) transcription is /cɔːˈtɒfədʒi/ in Received Pronunciation (British English) and /ɔːˈtɑːfədʒi/ in General American English.

Part of Speech: Non-count noun (uncountable noun). In specialized scientific nomenclature, plural forms such as autophagies may appear strictly when classifying distinct categorical modalities (e.g., microautophagy, macroautophagy, chaperone-mediated autophagy).

Grammatical Variants: The adjectival forms are autophagic (/cˌɔːtəˈfædʒɪk/) and occasionally autophagous. The intransitive and transitive verb forms are autophagocytose or colloquially autophagize, although contemporary scientific literature preferentially utilizes verb phrases such as “to undergo autophagy,” “to degrade via autophagy,” or “to induce autophagic flux.”

4. Detailed Conceptual Explanation

At its conceptual core, autophagy is the eukaryotic cell’s primary mechanism for clearing bulk cytoplasmic contents that cannot be degraded by the narrow pore of the ubiquitin-proteasome system (UPS). While the UPS specializes in the rapid degradation of short-lived, individual soluble proteins through ubiquitin tagging and destruction inside the 26S proteasome barrel, autophagy handles large structures, including multi-protein aggregates, whole organelles such as mitochondria and peroxisomes, and invading cytoplasmic microbes.

The canonical pathway of macroautophagy unfolds across five structurally and biochemically distinct phases: nucleation, elongation, closure, fusion, and degradation. During the initiation and nucleation phase, an intracellular nutritional or energetic stress signal prompts the formation of an isolated, curved membrane crescent known as the isolation membrane or phagophore. The phagophore originates primarily at specialized endoplasmic reticulum subdomains termed omegasomes, with contributions from the Golgi apparatus, endosomes, and the plasma membrane.

As the process progresses into the elongation phase, two evolutionary conserved ubiquitin-like conjugation cascades drive the expansion of the lipid bilayer around the targeted cytoplasmic cargo. The phagophore curves symmetrically until its opposing edges fuse together, fully sequestering the cargo within a spherical, sealed, double-membrane organelle designated the autophagosome. Crucially, the formation of the autophagosome encapsulates cytoplasm without possessing intrinsic digestive enzymes.

Following complete enclosure, the mature autophagosome is transported along microtubules toward the perinuclear region of the cell, where it encounters lysosomes. The outer membrane of the autophagosome fuses with the single membrane of a lysosome to form an autolysosome. This fusion exposes the inner autophagosomal vesicle and its packaged cargo to an array of acidic lysosomal hydrolases, including proteases, lipases, nucleases, and glycosidases. These enzymes rapidly degrade the contents into fundamental molecular building blocks, such as amino acids, free fatty acids, nucleosides, and simple sugars, which are transported back across the lysosomal membrane into the cytosol by specialized permeases to fuel metabolic homeostasis and maintain protein synthesis.

5. Historical Development

The historical trajectory of autophagy spans more than six decades, progressing from speculative electron microscopic observations to precise genetic dissection and targeted clinical therapeutics. In the mid-1950s, electron microscopists such as Keith Porter and George Palade first observed membrane-enclosed organelles containing partially degenerated mitochondrial fragments within mammalian kidney and liver cells. In 1963, Christian de Duve formally synthesized these observations and named the phenomenon autophagy during the Ciba Foundation Symposium on Lysosomes, a conceptual breakthrough that later contributed to his 1974 Nobel Prize in Physiology or Medicine.

For nearly three decades following de Duve’s formulation, autophagy remained primarily a morphological curiosity. Because researchers lacked biochemical and genetic markers to isolate the process, studying its molecular regulation was exceptionally difficult. The pivotal paradigm shift occurred in the early 1990s when Japanese cell biologist Yoshinori Ohsumi successfully visualized autophagic bodies accumulating inside the vacuoles of nutrient-deprived Saccharomyces cerevisiae mutants lacking vacuolar proteases.

Leveraging this yeast model, Ohsumi conducted landmark genetic screens that identified the fundamental genes indispensable for autophagosome biogenesis, originally designated APG and later standardized as ATG (Autophagy-related) genes. Ohsumi’s elucidation of the molecular cascades governing autophagosome construction demonstrated that the core machinery of autophagy is conserved from unicellular fungi to humans, a monumental achievement honored with the 2016 Nobel Prize in Physiology or Medicine.

Throughout the late 1990s and 2000s, researchers including Noboru Mizushima, Tamotsu Yoshimori, Beth Levine, and Daniel Klionsky translated these yeast discoveries into mammalian biology. Beth Levine’s discovery in 1999 that Beclin 1 (the mammalian ortholog of yeast Atg6) functions as a tumor suppressor established the decisive link between defective autophagy and human pathology. Subsequent decades have witnessed rapid diversification in autophagy research, clarifying selective autophagy receptors, organelle-specific clearance pathways, and the complex relationships linking autophagy to immunity, neurodegeneration, and aging.

6. Theoretical Foundations

The theoretical framework of autophagy relies heavily on systems biology, cellular energetics, and non-equilibrium thermodynamics. In bioenergetic terms, a living cell maintains high internal order and low entropy by expending free energy. When exterior nutrient inputs cease, the cell must catabolize internal non-vital structures to replenish intermediate metabolites, sustaining ATP production via oxidative phosphorylation and glycolysis. Autophagy thus represents the primary homeostatic buffering network preserving thermodynamic viability during bioenergetic crisis.

At the molecular signaling level, the theoretical regulation of autophagy is framed around an antagonistic signaling axis dominated by two master metabolic sensors: the mechanistic target of rapamycin complex 1 (mTORC1) and AMP-activated protein kinase (AMPK). Under conditions of nutrient abundance, high amino acid concentrations, insulin, and insulin-like growth factor signaling stimulate mTORC1. Active mTORC1 directly phosphorylates the unc-51-like autophagy activating kinase 1 (ULK1) complex, inhibiting its activity and suppressing autophagosome formation to favor anabolism and growth.

Conversely, under nutrient deprivation, low ATP-to-AMP ratios activate AMPK, the master cellular energy sensor. AMPK acts as a bidirectional molecular switch: it directly phosphorylates and activates ULK1 while concurrently phosphorylating and inactivating regulatory components of mTORC1. Release from mTORC1-mediated inhibition enables the ULK1 complex to translocate to the endoplasmic reticulum, initiating the phosphorylation of class III phosphatidylinositol 3-kinase (PI3K) complex components, culminating in the generation of phosphatidylinositol-3-phosphate (PI3P) and the recruitment of downstream effector proteins to orchestrate autophagosome biogenesis.

From an evolutionary theoretical perspective, autophagy is understood as an ancestral adaptation enabling early single-celled eukaryotes to survive severe fluctuations in environmental nutrient availability. As multicellular organisms evolved, this survival mechanism was co-opted to govern tissue remodeling during embryogenesis, cell fate decisions, immune vigilance, and the maintenance of post-mitotic cellular viability over long lifespans.

7. Key Components, Types & Dimensions

Autophagy is not a monolithic pathway; it encompasses multiple specialized modalities distinguished by cargo selectivity, delivery mechanics, and physiological triggers:

• Macroautophagy: The most extensively characterized form, involving the de novo synthesis of double-membrane autophagosomes that sequester cytosolic contents, transport them along the cytoskeleton, and fuse with lysosomes for degradation.
• Microautophagy: A process wherein the lysosomal (or vacuolar) membrane itself directly invaginates, engulfs, and internalizes cytoplasmic fragments without requiring an intermediate double-membrane autophagosome.
• Chaperone-Mediated Autophagy (CMA): A highly selective form of mammalian autophagy that does not involve vesicle packaging. Individual soluble proteins displaying a specific pentapeptide targeting motif (biochemically related to KFERQ) are recognized by the cytosolic chaperone heat shock cognate 71 kDa protein (Hsc70) and directly translocated into the lysosome lumen via the lysosomal-associated membrane protein 2A (LAMP-2A) receptor.
• Selective Organellophagy Subtypes: Specialized macroautophagic processes dedicated to the targeted elimination of distinct cellular organelles through cargo-specific receptor proteins, including:
  • Mitophagy: The targeted selective degradation of dysfunctional or depolarized mitochondria, primarily orchestrated via the PINK1-Parkin pathway or direct outer-mitochondrial membrane receptors (e.g., BNIP3, NIX).
  • Pexophagy: The selective removal of redundant or damaged peroxisomes to control reactive oxygen species and lipid metabolism.
  • Endoplasmic Reticulum Autophagy (ER-phagy/Reticulophagy): The remodeling and turnover of endoplasmic reticulum sheets and tubules in response to proteotoxic stress.
  • Ribophagy and Nucleophagy: The targeted elimination of ribosomes and nuclear envelope components, respectively.
  • Xenophagy: The selective recognition, ubiquitination, and engulfment of intracellular bacterial, viral, or protozoan pathogens by the autophagic machinery, representing a critical pillar of innate immunity.
  • Aggrephagy: The selective clearance of insoluble, ubiquitinated protein aggregates mediated by cargo receptor proteins such as p62/SQSTM1, NBR1, and OPTN.

8. Examples & Illustrative Cases

The physiological indispensability of autophagy is readily illustrated across diverse organ systems, particularly in long-lived, post-mitotic cells such as neurons and cardiomyocytes that cannot dilute toxic aggregates or damaged organelles through cell division.

A classic clinical illustration involves neurodegenerative diseases characterized by pathological protein accumulation, such as Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease. In familial Parkinson’s disease, loss-of-function mutations in the genes encoding PINK1 (a mitochondrial kinase) or PRKN (Parkin, an E3 ubiquitin ligase) prevent the cell from recognizing damaged, depolarized mitochondria. Because these defective mitochondria cannot undergo mitophagy, they accumulate in dopaminergic neurons of the substantia nigra, releasing cytotoxic reactive oxygen species and pro-apoptotic cytochrome c, which ultimately triggers premature neuronal death and characteristic motor dysfunction.

Another illustrative case is neonatal survival during the immediate post-natal transition. At birth, the sudden interruption of transplacental maternal nutrient supply creates an abrupt bioenergetic emergency in the newborn mammal. Within hours of birth, massive, systemic upregulation of macroautophagy occurs across tissues such as the liver, heart, and skeletal muscle. Neonatal mouse knockouts lacking critical autophagy genes (such as Atg5 or Atg7) appear structurally normal at birth but die within 12 to 24 hours due to profound systemic hypoglycemia and amino acid depletion, proving that autophagy is mandatory to sustain energy homeostasis before suckling supplies external nutrition.

In oncology, autophagy exhibits an illustrative paradoxical behavior known as the “autophagic switch.” In healthy or pre-malignant cells, basal autophagy serves as a formidable tumor suppressor by preventing chronic oxidative stress, preserving genomic stability, and purging oncogenic protein aggregates. However, once a solid tumor is established, poorly vascularized, hypoxic, and nutrient-deprived inner tumor cells upregulate autophagy as a survival mechanism, utilizing it to resist chemotherapy, survive ischemic microenvironments, and facilitate metastatic colonization.

9. Measurement & Assessment

Accurate quantification of autophagy in biological and clinical research requires rigorous methodologies designed to assess not merely the static abundance of autophagosomes, but rather autophagic flux—the complete dynamic progression through autophagosome formation, cargo delivery, lysosomal degradation, and product release.

A common misinterpretation in early studies was equating an increased steady-state quantity of autophagosomes with heightened autophagy; such accumulations can equally represent downstream lysosomal blockade or failed autophagosome clearance. Standardized international guidelines established by the scientific community (such as those compiled by Klionsky and colleagues) mandate complementary assessment techniques:

• LC3-II Western Blotting and Turnover Assays: Microtubule-associated protein 1A/1B-light chain 3 (LC3) is the standard mammalian marker for autophagosomal membranes. During autophagosome formation, cytosolic LC3-I is conjugated with phosphatidylethanolamine to generate LC3-II, which integrates into the phagophore. Dynamic flux is measured by comparing LC3-II levels in the absence and presence of lysosomal acidification inhibitors (e.g., bafilomycin A1 or chloroquine). A true induction of autophagy increases LC3-II accumulation upon lysosomal inhibition compared to baseline.
• p62/SQSTM1 Degradation Assays: Sequestosome 1 (p62) is a selective autophagy adapter that binds ubiquitinated proteins and delivers them to autophagosomes by docking with LC3. Because p62 is degraded alongside its cargo inside the autolysosome, steady-state levels of p62 inversely correlate with autophagic degradation activity under constant transcriptional rates.
• Fluorescent Tandem Biosensors (mRFP-GFP-LC3): This dual-fluorophore reporter leverages the differential pH sensitivities of Green Fluorescent Protein (GFP, which is acid-sensitive and quenched in acidic lysosomes) and Monomeric Red Fluorescent Protein (mRFP, which remains stable in low pH). Autophagosomes prior to fusion exhibit both red and green fluorescence (appearing yellow), whereas upon fusion with lysosomes, the GFP signal is quenched, leaving exclusively red-fluorescent autolysosomes.
• Transmission Electron Microscopy (TEM): TEM remains the gold standard for morphological resolution, enabling direct visualization of nascent isolation membranes, double-membrane autophagosomes containing recognizable cytoplasmic organelles, and electron-dense single-membrane autolysosomes.
• Flow Cytometry and High-Content Imaging: Automated fluorescent imaging techniques allow quantitative, high-throughput profiling of autophagic puncta per cell, facilitating large-scale pharmacological screens for novel autophagy inducers or inhibitors.

10. Applications & Practical Significance

The deliberate modulation of autophagy holds exceptional clinical and therapeutic promise across multiple branches of medicine, including pharmacology, oncology, geriatric medicine, and infectious disease control.

In pharmacological research, the pursuit of small-molecule autophagy modulators is divided into two distinct therapeutic strategies: therapeutic activation and therapeutic inhibition. Enhancing autophagy is a prominent target in treating neurodegenerative proteinopathies and decelerating age-associated cellular decline. Pharmacological agents such as rapamycin and rapalogs (which inhibit mTORC1), trehalose, spermidine, and caloric restriction mimetics (e.g., metformin) stimulate autophagic clearance of neurotoxic proteins like tau, mutant alpha-synuclein, and huntingtin, preserving neuronal architecture in experimental models.

Conversely, targeted autophagy inhibition is an active frontier in clinical oncology. Because advanced carcinoma cells rely on elevated autophagic flux to withstand the cellular stresses inflicted by radio- and chemotherapy, combining conventional antineoplastic treatments with lysosomotropic autophagy inhibitors such as chloroquine, hydroxychloroquine, or novel ULK1/Vps34 catalytic inhibitors sensitizes recalcitrant tumors to apoptosis.

In lifestyle medicine and preventive gerontology, understanding autophagy has illuminated the molecular mechanisms underpinning caloric restriction, intermittent fasting, and endurance exercise. Fasting and physical exertion deplete glycogen stores and elevate cellular AMP levels, triggering AMPK-driven autophagic waves that promote mitochondrial turnover, enhance metabolic flexibility, and reduce systemic low-grade chronic inflammation.

11. Research & Empirical Evidence

Extensive empirical studies in model organisms have confirmed the causal connection between autophagy, physiological resilience, and extended organismal lifespan. Foundational work by researchers such as Malene Hansen and David Kenyon established that genetic mutations prolonging lifespan in Caenorhabditis elegans—including mutations in the insulin/IGF-1 receptor daf-2—strictly require a functional autophagic pathway; silencing essential atg genes abolishes the observed lifespan extension.

In mammalian systems, pioneering work led by Noboru Mizushima and colleagues using conditional tissue-specific knockout mice provided incontrovertible evidence of autophagy’s organ-specific functions. Neural-specific ablation of Atg7 or Atg5 in mice, despite the total absence of any foreign pathogenic genes, caused spontaneous, progressive neurodegeneration characterized by widespread ubiquitin-positive inclusion bodies, extensive motor coordination deficits, and premature death, proving that baseline autophagy is indispensable for baseline neuronal proteostasis.

Similarly, seminal investigations by Beth Levine’s laboratory demonstrated that systemic genetic upregulation of autophagy extends healthspan and median longevity in mammals. Transgenic mice engineered to express a constitutively active mutant form of Beclin 1 (F121A knock-in), which reduces its inhibitory interaction with BCL2, exhibited continuous, elevated basal levels of systemic autophagy. These animals exhibited significantly increased median lifespans, reduced age-related cardiac and renal fibrosis, and diminished spontaneous tumorigenesis.

In clinical trials, researchers are actively assessing the safety and efficacy of combining hydroxychloroquine-mediated autophagy inhibition with targeted kinase inhibitors (e.g., BRAF inhibitors in melanoma) or conventional cytotoxic agents in metastatic pancreatic adenocarcinoma, demonstrating statistically meaningful improvements in progression-free survival in specific patient cohorts.

12. Cultural & Cross-Cultural Considerations

While the biochemical machinery of autophagy is universal across human populations, cultural interpretations and lifestyle practices linked to its induction vary markedly worldwide. Across diverse cultural, philosophical, and religious traditions, voluntary dietary restriction and fasting have been practiced for millennia—ranging from Islamic Ramadan and Christian Lent to Yom Kippur in Judaism and intermittent fasting regimens in Buddhist monastic traditions.

In contemporary public health discourse, the scientific popularization of autophagy following the 2016 Nobel Prize generated widespread interest across wellness, biohacking, and fitness cultures. However, the translation of complex molecular findings into consumer health spaces has often resulted in oversimplification. Mainstream media and wellness platforms frequently portray autophagy as an on-demand, instant “cellular reset” that can be triggered precisely by arbitrary fasting windows (e.g., 16 hours of intermittent fasting) or specific dietary supplements.

Cross-cultural biomedical perspectives also influence pharmacological approaches to autophagy. In East Asian integrative medicine contexts, substantial academic research focuses on identifying bioactive phytochemicals derived from traditional herbal pharmacopeias (e.g., berberine, curcumin, resveratrol, ginsenosides) that exhibit robust autophagy-modulating properties. Meanwhile, Western clinical pharmacology predominantly emphasizes the synthesis of highly specific, small-molecule kinase inhibitors targeting explicit crystallographic domains of enzymes such as ULK1, Vps34, and mTOR.

13. Criticisms, Debates & Limitations

Despite extraordinary scientific progress, the field of autophagy research faces significant methodological challenges, conceptual controversies, and therapeutic hurdles:

One enduring academic debate surrounds the concept of “autophagic cell death” (formerly classified as Type II programmed cell death). Historically, dying cells showing high quantities of autophagic vesicles under electron microscopy were presumed to die via autophagy. However, modern consensus from the Nomenclature Committee on Cell Death clarifies that the presence of autophagosomes does not necessarily mean autophagy is the executing lethal mechanism. In most instances, autophagy is an adaptive survival response deployed by a stressed cell that ultimately dies by apoptosis or necrosis despite this protective effort. True autophagic cell death—where cell death is mechanistically driven by the autophagic machinery and can be prevented by genetically silencing ATG genes—occurs only in very specific developmental or physiological settings.

A critical clinical challenge is the “double-edged sword” nature of autophagy in human disease, particularly oncology. Because autophagy can either suppress or promote tumor growth depending on the stage of malignancy, cellular context, and tissue microenvironment, administering global autophagy modulators risks unpredictable off-target effects. Inducing autophagy to protect normal tissues against chemotherapy-induced toxicity might inadvertently enhance the survival of dormant, resistant micrometastases.

Methodologically, measuring autophagic flux in living human patients remains a major obstacle. While researchers can accurately measure dynamic flux in cultured cells and genetically engineered animal models using fluorescent biosensors and lysosomal inhibitors, non-invasive, validated clinical biomarkers to measure real-time autophagic flux in human biopsy specimens or through blood-based assays are still limited, hindering the pharmacodynamic evaluation of novel therapeutics in clinical trials.

14. Related Terms & Distinctions

To prevent conceptual confusion, autophagy must be rigorously distinguished from several related cellular processes:

• Apoptosis: Unlike autophagy, which is primarily a catabolic survival and recycling mechanism, apoptosis is a form of programmed cell death characterized by cell shrinkage, chromatin condensation, membrane blebbing, and caspase-dependent fragmentation into apoptotic bodies without eliciting inflammation.
• Ubiquitin-Proteasome System (UPS): Both systems govern cellular proteostasis, but the UPS degrades short-lived, soluble, monomeric proteins that are specifically polyubiquitinated and threaded through the barrel of the 26S proteasome. Autophagy, by contrast, mediates bulk clearance of large, insoluble aggregates, complex multi-protein complexes, and entire organelles through membrane encapsulation and lysosomal fusion.
• Heterophagy: While autophagy degrades internal, endogenous cellular components (“self-eating”), heterophagy refers to the lysosomal degradation of exogenous, extracellular materials internalized via endocytosis or phagocytosis (“other-eating”).
• Phagocytosis: An actin-dependent form of endocytosis executed primarily by specialized professional immune cells (macrophages, neutrophils, dendritic cells) to engulf large extracellular particles (>0.5 μm), such as apoptotic cells and bacteria, directly from the extracellular space into a phagosome.
• Necroptosis: A regulated, programmed form of necrotic cell death that is caspase-independent and driven by RIPK1, RIPK3, and MLKL, resulting in plasma membrane rupture, organelle swelling, and the release of inflammatory damage-associated molecular patterns (DAMPs), contrasting sharply with the controlled degradation of autophagy.

15. Summary & Key Takeaways

Autophagy is an evolutionary conserved, lysosome-mediated catabolic pathway that degrades and recycles cytoplasmic proteins, damaged organelles, and pathogens. It plays an essential role in maintaining cellular homeostasis, energetic balance, and proteostasis across eukaryotic life. Controlled by complex signaling networks—principally the balance between the inhibitory nutrient sensor mTORC1 and the activating energy sensor AMPK—autophagy operates both as a continuous basal housekeeping system and as an inducible survival response during stress.

Dysfunctional autophagy is implicated in numerous human pathologies, including neurodegenerative disorders, cardiovascular deterioration, infectious vulnerabilities, metabolic disorders, and cancer. While the field faces ongoing challenges concerning biomarker detection in vivo and context-dependent therapeutic responses, manipulating autophagic flux remains one of the most promising frontiers in molecular medicine and biogerontology.

References

• de Duve, C., & Wattiaux, R. (1966). Functions of lysosomes. Annual Review of Physiology, 28(1), 435–492. https://doi.org/10.1146/annurev.ph.28.030166.002251
• Galluzzi, L., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo-San Pedro, J. M., Cecconi, F., … & Kroemer, G. (2017). Molecular definitions of autophagy and related processes. The EMBO Journal, 36(13), 1811–1836. https://doi.org/10.15252/embj.201796697
• Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., … & Tong, C. K. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1–382. https://doi.org/10.1080/15548627.2020.1797280
• Levine, B., & Kroemer, G. (2019). Biological functions of autophagy genes: A disease perspective. Cell, 176(1), 11–42. https://doi.org/10.1016/j.cell.2018.09.048
• Mizushima, N., & Komatsu, M. (2011). Autophagy: Renovation of cells and tissues. Cell, 147(4), 728–741. https://doi.org/10.1016/j.cell.2011.10.026
• Ohsumi, Y. (2014). Historical landmarks of autophagy research. Cell Research, 24(1), 9–23. https://doi.org/10.1038/cr.2013.169